PJP vs. HRTS

Last updated Jun 4, 2026

PJP (Invesco Dynamic Pharmaceuticals ETF) and HRTS (Tema Obesity & Cardiometabolic ETF) are both Health & Biotech Equities funds. PJP is passively managed, while HRTS is actively managed. Over the past year, PJP returned 34.73% vs 20.97% for HRTS. A 0.76 correlation means they provide meaningful diversification when combined. PJP charges 0.58%/yr vs 0.75%/yr for HRTS.

Performance

PJP vs. HRTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Tema Obesity & Cardiometabolic ETF (HRTS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PJP achieves a 2.90% return, which is significantly higher than HRTS's -5.70% return.

PJP

• 1D: 1.20%
• 1M: 1.29%
• YTD: 2.90%
• 6M: 2.29%
• 1Y: 34.73%
• 3Y*: 13.31%
• 5Y*: 7.62%
• 10Y*: 6.15%

HRTS

• 1D: 0.51%
• 1M: -0.90%
• YTD: -5.70%
• 6M: -5.48%
• 1Y: 20.97%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. HRTS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
PJP Invesco Dynamic Pharmaceuticals ETF	2.90%	27.98%	9.63%	9.01%
HRTS Tema Obesity & Cardiometabolic ETF	-5.70%	23.93%	-4.30%	14.97%

Correlation

The correlation between PJP and HRTS is 0.83, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.83
Correlation (All Time) Calculated using the full available price history since Nov 22, 2023	0.76

The correlation between PJP and HRTS has been stable across timeframes, ranging from 0.76 to 0.83 - a consistent structural relationship.

PJP vs. HRTS - Sectors Allocation Comparison

Sectors	PJP	HRTS
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

PJP vs. HRTS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP

PJP Risk / Return Rank: 64
PJP Sharpe Ratio Rank: 63
PJP Sortino Ratio Rank: 64
PJP Omega Ratio Rank: 57
PJP Calmar Ratio Rank: 73
PJP Martin Ratio Rank: 63

HRTS

HRTS Risk / Return Rank: 36
HRTS Sharpe Ratio Rank: 37
HRTS Sortino Ratio Rank: 38
HRTS Omega Ratio Rank: 33
HRTS Calmar Ratio Rank: 39
HRTS Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. HRTS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Tema Obesity & Cardiometabolic ETF (HRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PJP	HRTS	Difference
Sharpe ratio: Return per unit of total volatility	2.13	1.31	+0.82
Sortino ratio: Return per unit of downside risk	3.01	1.99	+1.02
Omega ratio: Gain probability vs. loss probability	1.36	1.23	+0.13
Calmar ratio: Return relative to maximum drawdown	3.70	1.91	+1.78
Martin ratio: Return relative to average drawdown	11.55	4.83	+6.72
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PJP vs. HRTS - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.13, which is higher than the HRTS Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of PJP and HRTS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PJP	HRTS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.13	1.31	+0.82
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.34	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	0.55	+0.04

Drawdowns

PJP vs. HRTS - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, which is greater than HRTS's maximum drawdown of -25.81%. Use the drawdown chart below to compare losses from any high point for PJP and HRTS.

Drawdown Indicators

	PJP	HRTS	Difference
Max Drawdown Largest peak-to-trough decline	-37.06%	-25.81%	-11.25%
Max Drawdown (1Y) Largest decline over 1 year	-9.44%	-11.01%	+1.57%
Max Drawdown (3Y) Largest decline over 3 years	-16.27%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-17.51%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-33.95%	—	—
Current Drawdown Current decline from peak	-2.94%	-9.14%	+6.20%
Average Drawdown Average peak-to-trough decline	-8.85%	-9.02%	+0.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.02%	4.36%	-1.34%

Volatility

PJP vs. HRTS - Volatility Comparison

Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to Tema Obesity & Cardiometabolic ETF (HRTS) at 4.44%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than HRTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PJP	HRTS	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.33%	4.44%	+0.89%
Volatility (6M) Calculated over the trailing 6-month period	12.02%	11.26%	+0.76%
Volatility (1Y) Calculated over the trailing 1-year period	16.38%	16.03%	+0.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.17%	19.07%	-2.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.39%	19.07%	-0.68%

PJP vs. HRTS - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is lower than HRTS's 0.75% expense ratio.

Dividends

PJP vs. HRTS - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, less than HRTS's 1.42% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HRTS Tema Obesity & Cardiometabolic ETF	1.42%	1.34%	1.63%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PJP Invesco Dynamic Pharmaceuticals ETF	0.99%	0.98%	0.97%	1.01%	0.95%	0.81%	0.75%	0.77%	1.12%	0.65%	0.91%	5.49%

Frequently Asked Questions

Can I hold both PJP and HRTS in my portfolio?

PJP and HRTS have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PJP or HRTS?

PJP has higher volatility (5.33%) compared to HRTS (4.44%). In terms of maximum drawdown, PJP dropped -37.06% vs HRTS's -25.81%.

Which ETF is better, PJP or HRTS?

On 1-year performance, PJP leads with 34.73% vs 20.97% for HRTS. On fees, PJP is cheaper at 0.58% per year. On volatility, HRTS has been the lower-risk option at 4.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PJP or HRTS?

Over the 1-year period, PJP has performed better with a 34.73% return vs 20.97%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PJP or HRTS?

PJP is cheaper with a 0.58% expense ratio, compared with 0.75% for HRTS.

Which ETF pays a higher dividend yield, PJP or HRTS?

HRTS has the higher dividend yield at 1.42%, compared with 0.99% for PJP.

What is the main difference between PJP and HRTS?

They also come from different issuers: Invesco and Tema. Their fees differ too: 0.58% for PJP and 0.75% for HRTS.

Which has better risk-adjusted returns?

PJP currently has the higher Sharpe Ratio (2.13 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.